New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 14, 2020, - Lupin launched an AT-rated generic version of Alcon’s Moxeza (moxifloxacin) 0.5% ophthalmic solution.
Download PDF
Return to publications
